137
views
0
recommends
+1 Recommend
4 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Impact of COVID-19 pandemic on health system & Sustainable Development Goal 3

      other

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The coronavirus disease 2019 (COVID-19) pandemic has overshadowed developmental activities across the world. The global political, financial and technical resources have been mobilized to contain COVID-19 pandemic. Impact of this pandemic shall be long-lasting, influencing all spheres of human lives and slowing all developmental activities including ambitious and aspirational Sustainable Development Goals (SDGs). SDGs were adopted by the global community in 20151 to improve the quality of life of all citizens and to carry forward unfinished agenda of the Millennium Development Goals (MDGs). Of the 17 SDGs2, SDG 3 focuses on health (Ensure Healthy Lives and Promote Well-being for All at All Ages). Combating COVID-19 pandemic is highest on the global agenda at present. Achievement of SDGs within the stipulated time frame of 2030 has become secondary. The duration of the ongoing pandemic cannot be predicted. The outcome and end point of pandemic remain uncertain. All SDGs are being impacted. Given their interconnected nature, health-related SDG 3 is also severely hit. SDG 3 is interwoven with, and draws complementarity from SDG 1 (Poverty), SDG 2 (Zero Hunger), SDG 4 (Quality Education), SDG 5 (Gender Equality), SDG 6 (Clean Water and Sanitation), SDG 13 (Climate Action), SDG 14 (Life under Water), SDG 15 (Life on Land) and SDG 17 (Partnerships for Goals)2. The sudden occurrence of COVID-193 has, as other pandemics did in the past, stonewalled achievements expected to be made through global collaborative efforts including SDGs. History of pandemics The COVID-19 pandemic is not the first, and certainly not the last to savagely hit the world4. Pandemics evoke nationwide focussed response and during the period, other services, including provision of healthcare are neglected. The pandemics test the structure and competence of the health system. Yet, post-pandemic period sees preferred efforts for the restoration of economic activities. Health system remains weak, at times getting weaker because of the impact of the pandemic5. The previous century saw three major pandemics: the first (Spanish flu) caused by influenza A (H1N1) killed around 20-50 million people and caused a loss in the global gross domestic product (GDP) of around 16 per cent6. The other two in 1957 and 1968 were relatively milder but still killed nearly one million6. A novel influenza virus made a dramatic appearance in Mexico in March 2009 in the form of a H1N1 subtype. The pandemic swept the whole world, and killed 18,449 people in 214 countries7. The last two decades of this millennium have made us confront the major events of huge public health importance including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), avian flu (Influenza H5N1), influenza (H1N1) and the ongoing COVID-19 due to SARS-CoV-28 9. This article is to reiterate that the lessons learnt from pandemics should not be forgotten once pandemics cease to exist. These must be translated into actions that are sustained on all-time basis. Learning from COVID-19 pandemic as well as accumulating experiences from previous pandemics (and even outbreaks such as Nipah in Kerala and epidemics of Ebola in Africa), the pandemic preparedness and response plan should be developed in such a way that the remaining health services are not disrupted. Current pandemic and health system Within four months of the appearance of the first case of COVID-19 in Wuhan, China, the entire world has been engulfed by a novel coronavirus named as SARS-CoV-210. As on May 12, 2020, a total of 4,098,018 confirmed cases with 283,271 deaths were reported11. In one day alone (May 12, 2020), 82,591 cases and 4,261 deaths were reported to the World Health Organization (WHO)11. The number of cases has been consistently increasing in several countries where the epidemic curve is refusing to flatten. It also indicates that because of the transmissibility of SARS-CoV-2 and inadequate effective response, larger number of cases and deaths are likely to take place in times to come. Global response to the COVID-19 pandemic has exposed inherent weaknesses in our preparedness and response. The health systems have been grossly overwhelmed by the pandemic. By the sheer nature of its preventive, curative, rehabilitative, restorative and health-promoting role, functional health systems are indispensable for any individual, community, society and the country not only for the physical and mental well-being of the people but also for the incrementally increasing overall economic productivity and human development. The need of quality and operational health system is continuous, and not time dependent or of short duration. Any disruption in access to quality service delivery is not only detrimental to human health but can also be responsible for loss of life and substantial economic losses. Institutional deliveries of newborn, care of mother and baby, protection of children from malnutrition and infectious diseases through vaccinations, health promotion, management of various acute and chronic diseases, surgical interventions for saving lives or restoring essential senses such as vision and hearing and responding to acute emergencies including trauma are some of the services that are at the core of the health system. Public health activities are an equally important arm of the health system in protecting the health of communities and keeping them engaged in preventing diseases and leading healthy and productive lives. Any sudden man-made or natural disaster-induced disruption in the seamless delivery of health services has the potential to severely impact most of the essential services. The COVID-19 pandemic has severely impacted the ongoing health programmes, curative services and achievements of SDG 312. A summary of the targets set under SDG 3 is shown in the [Box 1]. Box Summarized targets for Sustainable Development Goal 3 B 2030, 1. reduce the global maternal mortality ratio to <70 per 100,000 live births. 2. end preventable deaths of newborns and children under five years of age and reduce neonatal mortality to at least as low as 12 per 1000 live births and under-5 mortality to at least as low as 25 per 1000 live births. 3. end the epidemics of AIDS, TB, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases. 4. reduce by one-third pre-mature mortality from non-communicable diseases and promote mental health and well-being. 5. strengthen the prevention and treatment of substance abuse. 6. halve the number of global deaths and injuries from road traffic accidents. 7. ensure universal access to sexual and reproductive healthcare services. 8. achieve universal health coverage. 9. substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination. 3A. Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control. 3B. Support the research and development of vaccines and medicines for the communicable and non-communicable diseases. 3C. Substantially increase health financing and the recruitment, development, training and retention of the health workforce. 3D. Strengthen the capacity of all countries for early warning, risk reduction and management of national and global health risks. Source: Ref. 12 Achievements under SDG 3 till the onset of the COVID-19 pandemic Till the onset of the COVID-19 pandemic, major progress had been initiated in improving the health of millions of people across the world. Even in developing countries of Asia-Pacific, health indicators have seen better progress vis-a-vis for other SDGs13. The global progress includes increasing life expectancy, reducing maternal and child mortality and fighting against the leading non-communicable diseases (NCDs). Efforts have been enhanced to address the growing burden of NCDs, and to tackle antimicrobial resistance. The under-5 mortality rate fell to 39 deaths per 1000 live births in 201712. Coverage of the required three doses of the vaccine that prevents diphtheria, tetanus and pertussis increased from 72 per cent in 2000 to 85 per cent in 201712. Administration of the second dose of measles vaccine increased from 59 per cent in 2015 to 67 per cent in 201712. The rate of global HIV incidence among adults aged 15 to 49 declined overall by 22 per cent between 2010 and 201712. With an estimated 10 million people falling ill with tuberculosis (TB) annually, many of these with drug-resistant tubercle bacilli, elimination of TB remains high on the global agenda under SDG 3. Tobacco-related illnesses that killed more than 8.1 million in 201712 and a huge number of deaths due to road traffic accidents (1.35 million in 2016)12 are also priority health challenges throughout the world. NCDs have become major killers even in developing countries. These are a few parameters that clearly indicate the need for sustained efforts to maintain essential health services irrespective of exigencies of a pandemic. Impact of COVID-19 pandemic on health system and SDG 3 The COVID-19 pandemic has shifted priorities of the health system, which is finding itself not only overwhelmed but also with restricted capacity to provide services it has been hitherto extending to communities. Logistics and supplies are disrupted especially of material and equipment that were imported till date (API of essential drugs, personal protective equipment, to name a few) adversely affecting the services. Hospitals and health facilities overwhelmed with COVID-19 patients are making it difficult for other patients with acute or chronic ailments to access standard care. The national authorities have to plan for challenges related to health of its population concurrent with combating COVID-19 pandemic. Critical areas which may be given priority should address the needs of children, women, elderly with NCDs and others with special needs. The vulnerable should not be allowed to become more vulnerable. Children, women and elderly are the most vulnerable groups even in peace time. The gains of MDGs and SDGs stand to be negated unless the services for these groups are sustained. Health of children and women: Although the number of children affected and killed in the COVID-19 pandemic is miniscule as compared to adults and especially elderly14, the impact of the pandemic on their growth and protection against infectious diseases has been severely impacted. This pandemic will certainly cause reduced household income for a long time. Children and women along with the elderly will suffer most. The relationship between GDP and infant mortality rate (IMR) has been well known15. A huge number of children are likely to die in 2020 compared to a pre-pandemic scenario, thus reversing significantly successes in reducing IMR in the past few years. The world has been toiling hard to eliminate polio. The pandemic has caused the suspension of all polio vaccination campaigns worldwide. Wild and vaccine-derived polio viruses have been circulating in several countries16. Discontinuation of activities may provide the virus a milieu to spread further and faster. In addition, measles immunization campaigns have been suspended in 23 countries affecting almost 80 million eligible children16. Any disruption of immunization services, even for short periods, will result in an accumulation of susceptible individuals, and a higher incidence of vaccine preventable diseases16. The WHO and UNICEF have issued a Joint Statement calling for the implementation of routine immunization during pandemic. This is critical for reaching the most vulnerable children and protecting them from common infectious diseases17. Health of children is intractably linked with their nutrition status. Malnutrition predisposes children to several ailments and stunting of growth. With all schools closed indefinitely in 143 countries, 368.5 million children have been denied their daily school meals16, which shall certainly cause several deficiencies in these children. The UN Secretary General has indicated, through two Policy Brief papers of the United nations, one on children16 and one on women18, the challenges including antenatal and delivery care that have emerged and their possible solutions during the COVID-19 pandemic. Infectious diseases requiring continuous support of health system: Patients with TB and HIV/AIDS need continuous supply of medicines. Interruptions in the intake of medicine are getting frequent. This is not only detrimental to the health of the patient but is also associated with the risk of the development of resistance to specific therapy. Similarly, a large number of patients of NCDs including those who need periodic but regular administration of cancer therapies depend on health system for medicines, monitoring and care of complications. Non-availability of these products and services may have a serious negative impact on the physical and mental health of these people. The reporting for new cases of TB came down significantly in India during the period when social distancing was implemented across the country19. With the diversion of human resource to COVID-19 work, active case finding for TB has been deferred by some of the States in India19. It should be easy to infer that all public health programmes must be having similar setbacks. Management of NCDs and emergencies: Medical and surgical emergencies (including road accidents) get neglected when the entire health system is engaged in combating pandemic. These emergency services should be made available. The need for psychiatric support to patients and healthy populations is greater during pandemic and must be organized. Provisions for standard health services should be continued and supported by an efficient supply chain for essentials. Patients presenting with acute coronary syndromes, cancer care, immunosuppressive therapy, tumour resection and inpatient treatment have been disproportionately affected by COVID-19. Protocols for the management of many such conditions which required visit to health facility have to be changed. The impact on the health of these patients needs to be assessed and innovative solutions need to be implemented. Patients with terminal cancers require aggressive compassionate treatment which may be denied during the pandemic, giving rise to ethical issues. Fear of contracting SARS-CoV-2 prevents patients from seeking health care in healthcare facilities. These fears need to be dispelled and concomitantly supported by the provision of quality, safe and timely services20. Way forward Plans should be developed for a period of at least five years and subsequently revised in the light of technological advances and gains in knowledge. The State (or district and city specific) pandemic preparedness and response plan should have top policymakers of the State as the coordinators. Agreement of top political leadership and assurance of sustained funding are essential. In a set-up like India where district is the revenue unit, it is imperative to have a multisectoral multidisciplinary district pandemic preparedness and response plan in place. It must be kept in mind that while the focus of this preparation is to minimize the impact of pandemic, the preparedness helps health system even during the inter-pandemic period in providing improved services to communities to other diseases8. The key elements of plan21 should comprise surveillance (including data management), laboratory diagnosis, case management, Infection Prevention and Control, Research and Development, supply chains and community engagement, including support for mental health, and efficient supply chains for uninterrupted supply of personal protective equipment and ventilators, etc. The response to the pandemic cannot be de-linked from the SDGs. Indeed, achieving the SDGs will put us on a firm path to dealing with global health risks and emerging infectious diseases. Achieving SDG 3 will strengthen the national health systems22. The United Nations Development Programme (UNDP) has also advocated development and implementation of policies that strengthen health systems and accentuate response to any future pandemic23. In spite of the aspirational nature and global commitments to achieve SDGs, the progress till date has been suboptimal. The COVID-19 pandemic has further slowed down this process24. There will be a need for greater financial investment by the countries to reinvent and revigorate health systems and use COVID-19 as an opportunity to improve access, quality and safety of health system and promotion of factors that promote healthy lifestyles in days to come25.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

          Abstract Objectives To provide an overview of the three major deadly coronaviruses and identify areas for improvement of future preparedness plans, as well as provide a critical assessment of the risk factors and actionable items for stopping their spread, utilizing lessons learned from the first two deadly coronavirus outbreaks, as well as initial reports from the current novel coronavirus (COVID-19) epidemic in Wuhan, China. Methods Utilizing the Centers for Disease Control and Prevention (CDC, USA) website, and a comprehensive review of PubMed literature, we obtained information regarding clinical signs and symptoms, treatment and diagnosis, transmission methods, protection methods and risk factors for Middle East Respiratory Syndrome (MERS), Severe Acute Respiratory Syndrome (SARS) and COVID-19. Comparisons between the viruses were made. Results Inadequate risk assessment regarding the urgency of the situation, and limited reporting on the virus within China has, in part, led to the rapid spread of COVID-19 throughout mainland China and into proximal and distant countries. Compared with SARS and MERS, COVID-19 has spread more rapidly, due in part to increased globalization and the focus of the epidemic. Wuhan, China is a large hub connecting the North, South, East and West of China via railways and a major international airport. The availability of connecting flights, the timing of the outbreak during the Chinese (Lunar) New Year, and the massive rail transit hub located in Wuhan has enabled the virus to perforate throughout China, and eventually, globally. Conclusions We conclude that we did not learn from the two prior epidemics of coronavirus and were ill-prepared to deal with the challenges the COVID-19 epidemic has posed. Future research should attempt to address the uses and implications of internet of things (IoT) technologies for mapping the spread of infection.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The Untold Toll — The Pandemic’s Effects on Patients without Covid-19

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Likelihood of survival of coronavirus disease 2019

              A case fatality ratio of an infectious disease measures the proportion of all individuals diagnosed with a disease who will die from that disease. For an emerging infectious disease, this ratio is thus a very important indicator not only of disease severity but also of its significance as a public health problem. For instance, WHO estimated a case fatality ratio of approximately 14–15% for severe acute respiratory syndrome (SARS) in 2003, 1 and approximately 35% for Middle East respiratory syndrome (MERS) in 2012. 2 The ongoing pandemic of coronavirus disease 2019 (COVID-19) is caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), belonging to a large family of coronaviruses that also includes SARS coronavirus (SARS-CoV) and MERS coronavirus (MERS-CoV). COVID-19 was first reported in December, 2019, in Wuhan, in the Hubei province of China, and spread very rapidly to all other prefectures in Hubei, as well as all other provinces, autonomous regions, municipalities, and special administrative regions of China, and more than 180 other countries and territories. As of March 21, 2020, there have been 292 142 confirmed cases of COVID-19 worldwide, with 12 784 deaths reported. 3 Estimating the case fatality ratio for COVID-19 in real time during its epidemic is very challenging. Nevertheless, this ratio is a very important piece of data that will help to guide the response from various government and public health authorities worldwide. The disease has brought tremendous pressure and disastrous consequences for the public health and medical systems in Wuhan, as well as in Iran, Italy, and in other countries. However, current estimates of case fatality ratio for COVID-19 vary depending on the datasets and time periods examined. A study of nearly 1100 patients from China suggested a case fatality ratio of 1·4%. 4 From a dataset of 44 672 confirmed cases in China, a report from the Chinese Center for Disease Control and Prevention (CDC) 5 estimated an overall case fatality ratio of 2·3%, and pointed out that the ratio varied by location and intensity of transmission (eg, 2·9% in Hubei vs 0·4% in other areas of China), in different phases of the outbreak (eg, 14·4% before Dec 31, 15·6% for Jan 1–10, 5·7% for Jan 11–20, 1·9% Jan for 21–31, and 0·8% after Feb 1), as well as by sex (2·8% for males vs 1·7% for females). Moreover, the Chinese CDC reported that the case fatality ratio increases with age (from 0·2% for people aged 11–19 years, to 14·8% for people aged ≥80 years), and with the presence of comorbid conditions (10·5% for cardiovascular disease, 7·3% for diabetes, 6·0% for hypertension, 6·3% for chronic respiratory disease, and 5·6% for cancer). The WHO–China Joint Mission on COVID-19 provided similar data and reported a case fatality ratio of 3·8%, based on the 55 924 laboratory-confirmed cases in China. 6 In The Lancet Infectious Diseases, Robert Verity and colleagues 7 provide an estimate of the case fatality ratio for COVID-19. The authors argue that crude case fatality ratios obtained by simply dividing the number of deaths by the number of cases can be misleading because there can be a period of 2–3 weeks between a person developing symptoms and that case being detected and reported, and because surveillance of a novel virus is biased towards detecting severe cases, especially at the beginning of an outbreak when test capacity is low. By using individual-case data from mainland China (3665 cases) and 1334 cases detected outside of mainland China, assuming a constant attack rate by age, and adjusting for demography and age-based and location-based under-ascertainment, Verity and colleagues estimate the mean duration from symptom onset to death to be 17·8 days (95% credible interval [CrI] 16·9–19·2) and from onset-of-symptoms to hospital discharge to be 24·7 days (22·9–28·1). The study findings give an estimate of the overall case fatality ratio in China of 1·38% (95% CrI 1·23–1·53), which becomes higher as age increases (figure ). Figure Comparison of case fatality ratios for SARS,1, 8 COVID-19, 7 and seasonal influenza 9 SARS=severe acute respiratory syndrome. COVID-19=coronavirus disease 2019. CrI=credible interval. CI=confidence interval. Estimates of case fatality ratios might vary slightly from country to country because of differences in prevention, control, and mitigation policies implemented, and because the case fatality ratio is substantially affected by the preparedness and availability of health care. Early studies5, 6 have shown that delaying the detection of infected cases not only increases the probability of spreading the virus to others (most likely family members, colleagues, and friends) but also makes the infection worse in some cases, thereby increasing the case fatality ratio. 7 Comparisons of case fatality ratios for SARS, COVID-19, and seasonal influenza in different age groups are shown in the figure. Even though the fatality rate is low for younger people, it is very clear that any suggestion of COVID-19 being just like influenza is false: even for those aged 20–29 years, once infected with SARS-CoV-2, the mortality rate is 33 times higher than that from seasonal influenza. For people aged 60 years and older, the chance of survival following SARS-CoV-2 infection is approximately 95% in the absence of comorbid conditions. However, the chance of survival will be considerably decreased if the patient has underlying health conditions, and continues to decrease with age beyond 60 years.5, 6 Although China seems to be out of the woods now, many other countries are facing tremendous pressure from the COVID-19 pandemic. The strategies of early detection, early diagnosis, early isolation, and early treatment that were practised in China 6 are likely to be not only useful in controlling the outbreak, but also contribute to decreasing the case fatality ratio of the disease. © 2020 Hospital Clinic 2020 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
                Bookmark

                Author and article information

                Journal
                Indian J Med Res
                IJMR
                The Indian Journal of Medical Research
                Wolters Kluwer - Medknow (India )
                0971-5916
                0975-9174
                May 2020
                : 151
                : 5
                : 395-399
                Affiliations
                [1 ]South Asia Human & Social Development Division, Social Sector Specialist (Health), Asian Development Bank, New Delhi 110 002, India
                [2 ]Former Director, Communicable Diseases, World Health Organization South-East Asia Region Office, New Delhi 110 002, India
                Author notes
                Article
                IJMR-151-395
                10.4103/ijmr.IJMR_1920_20
                7530436
                32611910
                5995d5fb-e596-4624-a6ac-9c66a8679e81
                Copyright: © 2020 Indian Journal of Medical Research

                This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

                History
                Categories
                Perspective

                Medicine
                Medicine

                Comments

                Comment on this article